Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,078.50p
   
  • Change Today:
    -7.50p
  • 52 Week High: 1,425.00p
  • 52 Week Low: 1,018.50p
  • Currency: UK Pounds
  • Shares Issued: 872.51m
  • Volume: 437,710
  • Market Cap: £9,410m
  • RiskGrade: 173

Smith & Nephew FY operating profits double, CEO to depart

By Iain Gilbert

Date: Tuesday 22 Feb 2022

LONDON (ShareCast) - (Sharecast News) - Medical equipment manufacturer Smith & Nephew said on Tuesday that full-year operating profits had doubled in 2021, partly driven by a solid performance in its sports medicine and ENT and advanced wound management units.
S&N posted full-year revenues of $5.21bn, up 14.3% year-on-year on a reported basis and 10.3% on an underlying basis, while operating profits surged 101% to $593.0m and trading profits shot up from $683.0m to $936.0m as a result of a 300 basis point margin uplift due to improved trading impacts and discretionary cost control measures offsetting higher logistics costs.

Earnings per share were up 17% to 59.8 cents and the firm's full-year dividend of 37.5 cents was in line with both 2020 and 2019.

Chief executive Roland Diggelmann said: "We finished 2021 with a solid fourth quarter, despite nearly a week less trading than in 2020 and the impact of Omicron, which affected the typical quarter-end pick up in average daily sales.

"Looking to the future, we have set out our new strategy for growth with an ambition to transform to a structurally higher growth company, including clear medium-term revenue and trading profit margin targets. 2022 will be an important step on this journey as we continue to strengthen the business and invest behind innovation, while working to offset near-term headwinds. Smith & Nephew is well placed to continue to take advantage of the opportunities we see to drive shareholder returns, including through a new share buy-back programme."

Elsewhere, Smith & Nephew revealed that Dr Deepak Nath will take over from the outgoing Diggelmann on 1 April. Nath joins S&N from Siemens Healthineers, where most recently he was president of its diagnostics business segment and responsible for $6.0bn of sales and 15,000 employees.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,078.50p
Change Today -7.50p
% Change -0.69 %
52 Week High 1,425.00p
52 Week Low 1,018.50p
Volume 437,710
Shares Issued 872.51m
Market Cap £9,410m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.17% below the market average74.17% below the market average74.17% below the market average74.17% below the market average74.17% below the market average
52.63% above the sector average52.63% above the sector average52.63% above the sector average52.63% above the sector average52.63% above the sector average
Price Trend
42.3% below the market average42.3% below the market average42.3% below the market average42.3% below the market average42.3% below the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average
Income
22.58% below the market average22.58% below the market average22.58% below the market average22.58% below the market average22.58% below the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Growth
10.44% below the market average10.44% below the market average10.44% below the market average10.44% below the market average10.44% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 6
Sell 0
Strong Sell 1
Total 13
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Sep-22 31-Mar-22
Paid 26-Oct-22 11-May-22
Amount 14.40¢ 23.10¢

Trades for 09-Aug-2022

Time Volume / Share Price
11:41 300 @ 1,078.90p
11:41 1,180 @ 1,078.59p
11:41 32 @ 1,078.50p
11:41 280 @ 1,078.50p
11:41 249 @ 1,078.50p

Smith and Nephew Key Personnel

Chair Roberto Quarta
CEO Deepak Nath

Top of Page